White MK - Search Results

1

Treatment Tolerability in Patients with Immunoglobulin Light-Chain Amyloidosis.

Rizio AA, White MK, McCausland KL, Quock TP, Guthrie SD, Yokota M, Bayliss MS. Rizio AA, et al. Among authors: white mk. Am Health Drug Benefits. 2018 Nov;11(8):430-437. Am Health Drug Benefits. 2018. PMID: 30647830 Free PMC article.

2

Bayliss M, Rendas-Baum R, White MK, Maruish M, Bjorner J, Tunis SL. Bayliss M, et al. Among authors: white mk. Health Qual Life Outcomes. 2012 Dec 19;10:154. doi: 10.1186/1477-7525-10-154. Health Qual Life Outcomes. 2012. PMID: 23253258 Free PMC article.

3

A conceptual and disease model framework for osteoporotic kyphosis.

Bayliss M, Miltenburger C, White M, Alvares L. Bayliss M, et al. Osteoporos Int. 2013 Sep;24(9):2423-32. doi: 10.1007/s00198-013-2317-6. Epub 2013 Mar 28. Osteoporos Int. 2013. PMID: 23536254

4

The burden of amyloid light chain amyloidosis on health-related quality of life.

Bayliss M, McCausland KL, Guthrie SD, White MK. Bayliss M, et al. Among authors: white mk. Orphanet J Rare Dis. 2017 Jan 19;12(1):15. doi: 10.1186/s13023-016-0564-2. Orphanet J Rare Dis. 2017. PMID: 28103898 Free PMC article.

5

The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.

Rosenson RS, Miller K, Bayliss M, Sanchez RJ, Baccara-Dinet MT, Chibedi-De-Roche D, Taylor B, Khan I, Manvelian G, White M, Jacobson TA. Rosenson RS, et al. Cardiovasc Drugs Ther. 2017 Apr;31(2):179-186. doi: 10.1007/s10557-017-6723-4. Cardiovasc Drugs Ther. 2017. PMID: 28421332 Free PMC article.

6

Light Chain (AL) Amyloidosis: The Journey to Diagnosis.

McCausland KL, White MK, Guthrie SD, Quock T, Finkel M, Lousada I, Bayliss MS. McCausland KL, et al. Among authors: white mk. Patient. 2018 Apr;11(2):207-216. doi: 10.1007/s40271-017-0273-5. Patient. 2018. PMID: 28808991 Free PMC article.

7

A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time.

Sanchorawala V, McCausland KL, White MK, Bayliss MS, Guthrie SD, Lo S, Skinner M. Sanchorawala V, et al. Among authors: white mk. Br J Haematol. 2017 Nov;179(3):461-470. doi: 10.1111/bjh.14889. Epub 2017 Aug 29. Br J Haematol. 2017. PMID: 28850697 Free PMC article.

8

Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples.

White MK, McCausland KL, Sanchorawala V, Guthrie SD, Bayliss MS. White MK, et al. Patient Relat Outcome Meas. 2017 Dec 7;8:157-167. doi: 10.2147/PROM.S146849. eCollection 2017. Patient Relat Outcome Meas. 2017. PMID: 29263707 Free PMC article.

9

Humanistic burden of disease for patients with advanced melanoma in Canada.

Cheung WY, Bayliss MS, White MK, Stroupe A, Lovley A, King-Kallimanis BL, Lasch K. Cheung WY, et al. Among authors: white mk. Support Care Cancer. 2018 Jun;26(6):1985-1991. doi: 10.1007/s00520-017-4025-9. Epub 2018 Jan 10. Support Care Cancer. 2018. PMID: 29322243 Free PMC article.

10

A meta-analytic review of measurement equivalence study findings of the SF-36® and SF-12® Health Surveys across electronic modes compared to paper administration.

White MK, Maher SM, Rizio AA, Bjorner JB. White MK, et al. Qual Life Res. 2018 Jul;27(7):1757-1767. doi: 10.1007/s11136-018-1851-2. Epub 2018 Apr 16. Qual Life Res. 2018. PMID: 29663258 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page